4//SEC Filing
YK Bioventures Opportunities Fund I, L.P. 4
Accession 0001415889-24-029371
CIK 0001870404other
Filed
Dec 12, 7:00 PM ET
Accepted
Dec 13, 6:41 PM ET
Size
13.8 KB
Accession
0001415889-24-029371
Insider Transaction Report
Form 4
Transactions
- Sale
Common Stock
2024-12-12$0.07/sh−1,614,541$113,018→ 16,004,077 total(indirect: By YK Bioventures Opportunities Fund I, L.P.) - Sale
Common Stock
2024-12-11$0.08/sh−1,343,801$107,504→ 17,618,618 total(indirect: By YK Bioventures Opportunities Fund I, L.P.) - Sale
Common Stock
2024-12-13$0.06/sh−2,998,908$179,934→ 13,005,169 total(indirect: By YK Bioventures Opportunities Fund I, L.P.)
Kossar Mitchell William
10% Owner
Transactions
- Sale
Common Stock
2024-12-11$0.08/sh−1,343,801$107,504→ 17,618,618 total(indirect: By YK Bioventures Opportunities Fund I, L.P.) - Sale
Common Stock
2024-12-12$0.07/sh−1,614,541$113,018→ 16,004,077 total(indirect: By YK Bioventures Opportunities Fund I, L.P.) - Sale
Common Stock
2024-12-13$0.06/sh−2,998,908$179,934→ 13,005,169 total(indirect: By YK Bioventures Opportunities Fund I, L.P.)
Transactions
- Sale
Common Stock
2024-12-12$0.07/sh−1,614,541$113,018→ 16,004,077 total(indirect: By YK Bioventures Opportunities Fund I, L.P.) - Sale
Common Stock
2024-12-11$0.08/sh−1,343,801$107,504→ 17,618,618 total(indirect: By YK Bioventures Opportunities Fund I, L.P.) - Sale
Common Stock
2024-12-13$0.06/sh−2,998,908$179,934→ 13,005,169 total(indirect: By YK Bioventures Opportunities Fund I, L.P.)
Yeung Gary Kahing
10% Owner
Transactions
- Sale
Common Stock
2024-12-12$0.07/sh−1,614,541$113,018→ 16,004,077 total(indirect: By YK Bioventures Opportunities Fund I, L.P.) - Sale
Common Stock
2024-12-11$0.08/sh−1,343,801$107,504→ 17,618,618 total(indirect: By YK Bioventures Opportunities Fund I, L.P.) - Sale
Common Stock
2024-12-13$0.06/sh−2,998,908$179,934→ 13,005,169 total(indirect: By YK Bioventures Opportunities Fund I, L.P.)
Footnotes (1)
- [F1]Securities are held directly by YK Bioventures Opportunities Fund I, L.P. (f/k/a YK Bioventures, LLC) ("YK Opps I"). YK Bioventures Opportunities GP I, LLC ("YK Opps I GP") is the general partner of YK Opps I and may be deemed to beneficially own the shares held by YK Opps I. Mitchell W. Kossar and Gary K. Yeung are managing partners of YK Opps I GP, and may be deemed to share voting and investment power over the shares held by YK Opps I. Each of YK Opps I GP and Messrs. Kossar and Yeung disclaims beneficial ownership of these shares except to the extent of its or his respective pecuniary interest therein.
Documents
Issuer
CERO THERAPEUTICS HOLDINGS, INC.
CIK 0001870404
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0002042636
Filing Metadata
- Form type
- 4
- Filed
- Dec 12, 7:00 PM ET
- Accepted
- Dec 13, 6:41 PM ET
- Size
- 13.8 KB